Articles > Popular publications > PR Newswire press releases > July-September 2006 > Thursday, July 6

Article: Barr Confirms Patent Challenge of Razadyne(R) ER Capsules.

Article from:
PR Newswire
Article date:
July 6, 2006
Copyright

WOODCLIFF LAKE, N.J., July 6 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today confirmed that Janssen Pharmaceutica N.V., Janssen, L.P., Ortho-McNeil Neurologics, Inc. and Synaptech, Inc. ("Plaintiff") filed suit against it and its subsidiary, Barr Laboratories, Inc., relating to the patent protecting Razadyne(R) ER (Galantamine Hydrobromide Extended-Release Capsules), 8 mg, 16 mg and 24 mg. The Company indicated it believes it is the first to file an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) for the product.

Barr filed an ANDA with the FDA for Janssen's Razadyne ER (Galantamine Hydrobromide Extended-Release ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Barr Announces Favorable Ruling in Razadyne(R) Patent Challenge.
PR Newswire;  August 28, 2008 ;     700+ words ... ... and Barr's generic Razadyne ER (galantamine hydrobromide ... respect to the generic Razadyne ER product. Razadyne ... to IMS sales data. Razadyne ER capsules had annual ... com/. Forward-Looking Statements This communication ...

Article: Barr Receives Approval for Generic Version of Razadyne(R) ER ...
PR Newswire;  September 16, 2008 ;     700+ words ... ... given effect in the Razadyne ER litigation. Therefore ... to Barr's generic Razadyne ER (galantamine hydrobromide ... release capsules. Razadyne ER had annual sales of ... com/. Forward-Looking Statements This communication ...

Article: Barr Receives Approval for Generic Version of Razadyne(R) ...
PR Newswire;  August 28, 2008 ;     700+ words ... ... Barr's generic Razadyne ER (galantamine hydrobromide ... com/. Forward-Looking Statements This communication contains "forward-looking statements" which represent ... are "forward-looking statements" under the Private ...

Article: Shire plc: IFRS Results for the Year Ending December 31, 2007.
PR Newswire;  March 25, 2008 ;     700+ words ... ... that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties ... trademark of Johnson & Johnson) RAZADYNE ER (galantamine) (trademark of Johnson ...

Article: Shire plc: IFRS Information - First Half of 2006.
PR Newswire Europe;  September 18, 2006 ;     700+ words ... ... that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties ... trademark of Johnson & Johnson) RAZADYNE ER (trademark of Johnson & Johnson ...

Article: SHIRE PLC - IFRS results for the year ending December 31, 2006.
PR Newswire UK Disclose;  March 23, 2007 ;     700+ words ... ... that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties ... trademark of Johnson & Johnson) RAZADYNE ER (trademark of Johnson & Johnson ...

Article: Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R).
PR Newswire;  August 28, 2008 ;     700+ words ... ... outcome of this case. RAZADYNE and RAZADYNE ER are marketed by Ortho-McNeil Neurologics ... press release contains "forward-looking statements" as defined in the Private Securities ... undertake to update any forward- looking statements as a result of new information or ...

Article: Correcting Company Name in Forward-Looking ...
Business Wire;  February 10, 2000 ;     420 words ... ... release contains forward-looking statements that, if not verifiable ... be viewed as forward-looking statements that could predict future ... implied in such forward-looking statements. (sted This press release ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives